Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins.
about
Nonsurgical therapy for hydrocephalus: a comprehensive and critical reviewTherapeutic use of botulinum toxin in migraine: mechanisms of action.Volume-targeted therapy of increased intracranial pressure: the Lund concept unifies surgical and non-surgical treatments.Aspects on the Physiological and Biochemical Foundations of Neurocritical CareThe effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide.
P2860
Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Effects of dihydroergotamine a ...... peripheral arteries and veins.
@en
Effects of dihydroergotamine a ...... peripheral arteries and veins.
@nl
type
label
Effects of dihydroergotamine a ...... peripheral arteries and veins.
@en
Effects of dihydroergotamine a ...... peripheral arteries and veins.
@nl
prefLabel
Effects of dihydroergotamine a ...... peripheral arteries and veins.
@en
Effects of dihydroergotamine a ...... peripheral arteries and veins.
@nl
P2093
P2860
P1476
Effects of dihydroergotamine a ...... peripheral arteries and veins.
@en
P2093
Björkman S
Nordström CH
P2860
P304
P356
10.1111/J.1399-6576.1997.TB04641.X
P407
P577
1997-11-01T00:00:00Z